BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 18335524)

  • 41. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
    Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
    FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
    Ishii T; Furuoka H; Muroi Y; Nishimura M
    J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.
    Naert G; Ferré V; Meunier J; Keller E; Malmström S; Givalois L; Carreaux F; Bazureau JP; Maurice T
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2170-82. PubMed ID: 26381812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation.
    Zhao R; Zhang Z; Song Y; Wang D; Qi J; Wen S
    J Ethnopharmacol; 2011 Feb; 133(3):1109-16. PubMed ID: 21129477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
    Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
    Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
    Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S
    J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights concerning insulin synthesis and its secretion in rat hippocampus and cerebral cortex: amyloid-β1-42-induced reduction of proinsulin level via glycogen synthase kinase-3β.
    Nemoto T; Toyoshima-Aoyama F; Yanagita T; Maruta T; Fujita H; Koshida T; Yonaha T; Wada A; Sawaguchi A; Murakami M
    Cell Signal; 2014 Feb; 26(2):253-9. PubMed ID: 24269535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study of the protection and mechanism of IGF-1 on tau protein hyperphosphorylation in PC12 cells induced by Abeta(1-40)].
    Wang PJ; Zhang Y; Song RR; Shen DF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):960-4. PubMed ID: 21265094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation.
    Hoppe JB; Frozza RL; Horn AP; Comiran RA; Bernardi A; Campos MM; Battastini AMO; Salbego C
    J Pineal Res; 2010 Apr; 48(3):230-238. PubMed ID: 20136701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.
    Annamalai B; Won JS; Choi S; Singh I; Singh AK
    Biochem Biophys Res Commun; 2015 Feb; 458(1):214-9. PubMed ID: 25640839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
    Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
    CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glial cell line-derived neurotrophic factor-mediated enteric neuronal survival involves glycogen synthase kinase-3beta phosphorylation and coupling with 14-3-3.
    Mwangi S; Anitha M; Fu H; Sitaraman SV; Srinivasan S
    Neuroscience; 2006 Nov; 143(1):241-51. PubMed ID: 16996218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells.
    Zeng KW; Ko H; Yang HO; Wang XM
    Neuropharmacology; 2010 Nov; 59(6):542-50. PubMed ID: 20708632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endoplasmic reticulum stress mediates JNK-dependent IRS-1 serine phosphorylation and results in Tau hyperphosphorylation in amyloid β oligomer-treated PC12 cells and primary neurons.
    Zhang X; Tang S; Zhang Q; Shao W; Han X; Wang Y; Du Y
    Gene; 2016 Aug; 587(2):183-93. PubMed ID: 27185631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TPPU protects tau from H
    Yao ES; Tang Y; Liu XH; Wang MH
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alzheimer's disease genetic mutation evokes ultrastructural alterations: correlation to an intracellular Abeta deposition and the level of GSK-3beta-P(Y216) phosphorylated form.
    Pajak B; Songin M; Strosznajder JB; Gajkowska B
    Neurotoxicology; 2009 Jul; 30(4):581-8. PubMed ID: 19501118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576.
    Chauhan NB; Siegel GJ; Feinstein DL
    Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.